Erskine Chambers

Company law, corporate insolvency (cross border and domestic), financial services, LLP, partnership and related commercial litigation. Currently, about 75% of cases are contentious matters, with the remainder being non-contentious advisory work. Notable recent cases include: Re Carillion Plc (acting for respondent in disqualification proceedings); acting for successful claimant securing $300m buy-out award in DIFC LCIA unfair prejudice arbitration; 1Globe Capital LLC v Sinovac Biotech Ltd [2024] (Privy Council concerning validity of poison pill agreements and conduct of AGMs); Saxby v UDG Healthcare (UK) Holdings Ltd [2021] successful resistance of fraudulent misrepresentation claim relating to earn-out targets; Organic Grape Spirit Ltd v Nueva IQT SL [2020] review by CA of authorities on proviso to freezing order; Re Sturgeon Central Asia Balanced Fund [2020] termination of recognition order under cross-border insolvency regulations; Burnden Holdings (UK) Ltd v Fielding [2019] (acting for successful Defendants resisting fraud claims by liquidator relating to distribution); various large commercial arbitrations. Company advisory work includes many reductions of capital and members’ schemes of arrangement.

Called 1994; Gray’s Inn; Silk 2013

Publications: ‘Practice & Procedure of the Companies Court’ (1997); ‘Company Directors: Law and Liability’ (1997).

Fluent Spanish.

COMBAR; Chancery Bar Association.